EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Refractory solar lentigines successfully treated with 532‐nm nanosecond Nd:YAG Vasculature Salvage Laser Surgery (VSLS) system: Case series

So Young Lee iD, Ka Ram Kim, Seunghyeon Kim, Hye Sung Han, Ji Yeon Hong, Joon Seok, Kui Young Park

Skin Research and Technology · 2024

DOI: 10.1111/srt.70055 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Skin Research and Technology, 2024. Verfasst von So Young Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, College of Medicine, Chung-Ang University, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Lasers, Solid-State, Lentigo. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Chung-Ang University Research Scholarship Grants in 2024, Technology Development Program-Material and component technology development project, Ministry of Trade, Industry & Energy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Solar lentigo, a common epidermal hyperpigmented lesion found in sun‐exposed areas, results from the proliferation of melanocytes and the accumulation of melanin. Although various treatments for solar lentigo have been explored, they often lead to complications, including prolonged erythema and post‐inflammatory hyperpigmentation (PIH), posing significant concerns. Objectives and methods This study evaluated the safety and efficacy of the Vasculature Salvage Laser Surgery (VSLS) system. We treated six Korean patients, each with solar lentigo, in a single session using the 532‐nm nanosecond neodymium‐doped yttrium aluminum garnet (Nd:YAG) VSLS system, with follow‐up periods ranging from 3 to 10 weeks.

Results

The treatment led to the complete removal of pigmented lesions in all patients without resulting in PIH, even in cases where previous laser treatments had failed. The only side effect observed was mild erythema, which resolved over the long term in most instances.

Conclusions

The VSLS system emerges as a safe and effective treatment for pigmented lesions, including refractory solar lentigines. Nonetheless, additional studies are required to verify its long‐term efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lasers, Solid-StateLentigoHumansFemaleMaleMiddle AgedAdultTreatment OutcomeAgedLaser TherapySunlightHyperpigmentation

Stichwörter der Autor:innen

Nd:YAG laserVSLS systempigmented lesionspostinflammatory hyperpigmentationsolar lentigo

Autor:innen und Institutionen

  • Department of Dermatology, College of Medicine, Chung-Ang University, Seoul, Republic of Korea.
  • Department of Dermatology, Chung-Ang University Gwangmyeong Hospital, Chung-Ang University College of Medicine, Gwangmyeong-si, Republic of Korea.

ORCID-Profile: So Young Lee

Förderung

  • Chung-Ang University Research Scholarship Grants in 2024
  • Technology Development Program-Material and component technology development project
  • Ministry of Trade, Industry & Energy

Zitieren

APA

Lee, S. Y., Kim, K. R., Kim, S., Han, H. S., Hong, J. Y., Seok, J., & Park, K. Y. (2024). Refractory solar lentigines successfully treated with 532‐nm nanosecond Nd:YAG Vasculature Salvage Laser Surgery (VSLS) system: Case series. Skin Research and Technology. https://doi.org/10.1111/srt.70055

Vancouver

Lee SY, Kim KR, Kim S, Han HS, Hong JY, Seok J, et al. Refractory solar lentigines successfully treated with 532‐nm nanosecond Nd:YAG Vasculature Salvage Laser Surgery (VSLS) system: Case series. Skin Research and Technology. 2024. doi:10.1111/srt.70055

BibTeX
@article{Lee2024,
  author = {Lee, So Young and Kim, Ka Ram and Kim, Seunghyeon and Han, Hye Sung and Hong, Ji Yeon and Seok, Joon and Park, Kui Young},
  title = {Refractory solar lentigines successfully treated with 532‐nm nanosecond Nd:YAG Vasculature Salvage Laser Surgery (VSLS) system: Case series},
  journal = {Skin Research and Technology},
  year = {2024},
  doi = {10.1111/srt.70055}
}
Kostenlos starten →